Wellington Group’s Abbott ABT Stock Holding History

Wellington Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-264	Closed	-$27.1K	–	146
2026 Q1	$27.1K	Sell	264 -105	-28%	-$11.9K	0.01%	351
2025 Q4	$46.2K	Buy	+369	New	+$47K	0.02%	265

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Group's ABT Position: Q2 2026 in Review

Wellington Group sold out of Abbott (ABT) in Q2 2026, closing a stake of 264 shares — an estimated $27.1K sold.

Wellington Group first reported a position in ABT in Q4 2025 and held it in 2 quarters. The position peaked at $46.2K in Q4 2025. 2,965 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Wellington Group reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Wellington Group sold 264 Abbott shares in Q2 2026, an estimated $27.1K.
Wellington Group first reported a position in Abbott in Q4 2025 and held it in 2 quarters.
Wellington Group's Abbott position peaked at $46.2K in Q4 2025.
2,965 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Wellington Group's 13F filing for Q2 2026, filed 14 Aug 2026.